Report - Qualitätszirkel pharmaSuisse Studien KVS III Niedermolekulare Heparine (NMH): Fondaparinux-Studie (Folie 161) Orale Faktor Xa-Inhibitoren: Rivaroxaban-Studien.

Please pass captcha verification before submit form